1165: SARS-COV-2 VACCINATION INDUCES A PREDOMINENTLY CLASS II (CYTOKINE EFFECTOR) T CELL RESPONSE, BUT THE CLASS I RESPONSE IS AUGMENTED BY ANTI-TNF THERAPY AND VACCINE TYPE

Detalles Bibliográficos
Autores principales: Xu, Alexander, Li, Dalin, Elyanow, Rebecca, Gittelman, Rachel M., Chapman, Heidi, Prostko, John, Pozdnyakova, Valeriya, Debbas, Philip, Mujukian, Angela, Horizon, Arash A., Sobhani, Kimia, Cheng, Susan, Kaplan, Ian M., Mcgovern, Dermot P.B., Merchant, Akil, Melmed, Gil, Braun, Jonathan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AGA Institute. Published by Elsevier Inc. 2022
Materias:
AGA Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212302/
http://dx.doi.org/10.1016/S0016-5085(22)60659-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212302/
http://dx.doi.org/10.1016/S0016-5085(22)60659-0

Ejemplares similares